Several scientific studies — particularly from the University of Waikato (New Zealand) and UAE University — have investigated the effects of Manuka honey on various cancer cells, including breast cancer.
Laboratory (in vitro) experiments have shown that:
Manuka honey contains bioactive compounds such as methylglyoxal (MGO), flavonoids, and phenolic acids, which can induce apoptosis (cell death) in cancer cells.
These effects have been seen in breast, colon, and skin cancer cell lines.
Importantly, some studies noted that normal, healthy cells were not harmed, suggesting selective cytotoxicity.
However, these findings are limited to lab settings (not human trials), meaning:
Results are promising but not yet clinically proven.
More animal studies and clinical trials are needed to verify safety and efficacy in real-world scenarios.
Laboratory (in vitro) experiments have shown that:
Manuka honey contains bioactive compounds such as methylglyoxal (MGO), flavonoids, and phenolic acids, which can induce apoptosis (cell death) in cancer cells.
These effects have been seen in breast, colon, and skin cancer cell lines.
Importantly, some studies noted that normal, healthy cells were not harmed, suggesting selective cytotoxicity.
However, these findings are limited to lab settings (not human trials), meaning:
Results are promising but not yet clinically proven.
More animal studies and clinical trials are needed to verify safety and efficacy in real-world scenarios.
Several scientific studies — particularly from the University of Waikato (New Zealand) and UAE University — have investigated the effects of Manuka honey on various cancer cells, including breast cancer.
Laboratory (in vitro) experiments have shown that:
Manuka honey contains bioactive compounds such as methylglyoxal (MGO), flavonoids, and phenolic acids, which can induce apoptosis (cell death) in cancer cells.
These effects have been seen in breast, colon, and skin cancer cell lines.
Importantly, some studies noted that normal, healthy cells were not harmed, suggesting selective cytotoxicity.
However, these findings are limited to lab settings (not human trials), meaning:
Results are promising but not yet clinically proven.
More animal studies and clinical trials are needed to verify safety and efficacy in real-world scenarios.
0 Commentaires
·0 Parts
·20KB Vue
·0 Aperçu
